Clinical trial pipeline · Data from ClinicalTrials.gov
See which HER2 Expression Gastric Cancer/Gastroesophageal Junction Adenocarcinoma trials you may qualify forThis is an open,multicentre phase Ib/II study. The purpose of phase Ib is to evaluated the safety, tolerability, pharmacokinetics, immunogenicity, and prelimina…
The purpose of this study is to evaluate the efficacy and safety of Disitamab Vedotin combined with Trastuzumab and Tislelizumab Versus Chemotherapy Combined wi…
The dose escalation phase of this trial identifies the safety, side effects and best dose of ceralasertib (AZD6738) when given in combination with trastuzumab d…
This trial is a multi-center, open, single-arm, superior phase II clinical study.